Association between HLA-DRB1*04:05 and the efficacy of immune checkpoint inhibitors for patients with advanced cancer - Quiz - MDSpire

Association between HLA-DRB1*04:05 and the efficacy of immune checkpoint inhibitors for patients with advanced cancer

  • By

  • Mayu Watanabe

  • Jun Eguchi

  • Atsushi Takamoto

  • Jun Wada

  • June 10, 2026

  • 0 min

Share

Original Source(s)

Association between HLA-DRB1*04:05 and the efficacy of immune checkpoint inhibitors for patients with advanced cancer

  • by Mayu Watanabe, Jun Eguchi, Atsushi Takamoto, Jun Wada

  • June 10, 2026

Related Content

Impact of clinical pharmacist-led medication management and education on tacrolimus therapeutic control

Successful rescue therapy with eculizumab for probable tislelizumab-related MMM overlap syndrome with dual positivity for anti-acetylcholine receptor and anti-titin antibodies: a case report and literature review

The value of robot-assisted gastrectomy in the treatment of gastric cancer: a systematic review and meta-analysis